Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SenseIT
Rockville, Maryland, United Statessense-it.io ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Commercial
01
Overview
Lead asset solnerstotug (monoclonal antibody targeting VISTA) in Phase 1/2 for solid tumors. SNS-VISTA in lead generation. SNS–401-NG ImmunoPhage cocktail in preclinical development for Merkel cell carcinoma. Early pipeline includes bispecific and monoclonal antibodies targeting immune checkpoints and co-stimulatory molecules.
No published pivotal efficacy results as of June 2025.
Collaboration with University of Washington on solnerstotug program.
Platforms designed to enable selective activity within the tumor microenvironment and unlock previously undruggable targets.
Company has reduced headcount and focused pipeline as of early/mid–2025.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyBispecific antibodyNanobody therapy (alpaca-derived nanobodies)Bacteriophage-based immunotherapy ("ImmunoPhage")
- Industry
- Biotech
02
Partnerships
University of Washington - Preclinical studies for solnerstotug
Beyond the preview
Go deeper on SenseIT.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SenseIT.